Skip to main content
. 2004 Feb;2(1):29–35. doi: 10.3121/cmr.2.1.29

Table 5.

Possible Rapid Testing / Treatment Strategies (prevalence = 10.7%; sensitivities and specificities as noted in table 3).

Clients (N = 1384) Infections (n = 148)

Strategy % (#) Tested % (#) Treated same day** % (#) Treated (theoretic maximum)*** % (#) Treated on same day** % (#) Likely to be left untreated****
Presumptive Treatment with no testing 0% (0) 22.5% (312) 48.6% (72) 48.6% (72) 51.4% (76)
Presumptive Treatment plus Universal Culture (standard in clinic before study) 100% (1384) 22.5% (312) 75.7% (112) 48.6% (72) 29.7% (44)
Presumptive Treatment with selective PCR testing* 77.5% (1072) 22.5% (312) 96.6% (143) 48.6% (72) 12.8% (19)
Universal PCR; no presumptive treatment 100% (1384) 0% (0) 95.3% (141) 0% (0) 23.6% (35)
Universal point-of-care OIA testing; treat if OIA positive 100% (1384) 7.7% (106) 64.2% (95) 64.2% (95) 35.8% (53)
Universal point-of-care DFA testing; treat if DFA positive 100% (1384) 7.9% (110) 73.6% (109) 73.6% (109) 26.4% (39)
Presumptive Treatment plus selective point-of-care OIA testing* 77.5% (1072) 25.7% (356) 78.4% (116) 78.4% (116) 21.6% (32)
Presumptive Treatment plus selective point-of-care DFA testing* 77.5% (1072) 25.8% (357) 79.1% (117) 79.1% (117) 20.9% (31)

*for those not meeting presumptive treatment criteria.

**assuming 100% compliance with waiting for positive results and accepting same-day treatment.

***assuming 0% failure to return rate, and 100% compliance waiting for positive results and accepting same-day treatment.

****assuming 20% failure to return rate if not treated same-day in clinic.